84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2019-000580-24-GB (EUCTR) | 17/05/2019 | 25/03/2019 | A clinical trial of the antibiotic azithromycin for patients with sarcoidosis | A single arm, open-label clinical trial of azithromycin in pulmonary sarcoidosis - Azithromycin for sarcoidosis | Sarcoidosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08] | Trade Name: Azithromycin Product Name: Azithromycin INN or Proposed INN: azithromycin monohydrate | Hull & East Yorkshire Hospitals NHS trust | NULL | Not Recruiting | Female: yes Male: yes | 30 | Phase 2 | United Kingdom |